Time and Location:
07 – 09 May 2024 |Pennsylvania Convention Center, Philadelphia
INTRODUCTION
CPHI creates connections and inspires partnerships across the global pharma community. Access endless opportunity to grow your business and expand your network at the heart of Pharma!
We’re thrilled to announce that our Senior Regulatory Affairs Raymond Ng will take the stage to present Accestra Consulting. He will share valuable insights and expertise on the topics of China Drug Master File (DMF) Comparing with U.S. and EU.
Presentation:China Drug Master File (DMF) Comparing with U.S. and EU
May 7th 2024, 15:00-15:25 (EST)
Key Takeaway Points
- China DMF regulatory framework & reform
- China DMF registration pathways & requirements
- Registration procedures, timeline & costs
- Comparison of China DMF with U.S. & EU
- Technical requirements: pitfalls & tips
Presenter:
Raymond Ng,Accestra Consulting Company Senior Regulatory Affairs Manager
- Mr. Ng is based in China with almost a decade of regulatory affairs experience for Chinese market with a master’s degree from the University of Nottingham.
- He has extensive knowledge of Chinese pharmaceutical regulatory requirements and has worked on numerous regulatory submissions with Health Authorities.
- Mr. Ng has strong communication and practical experience dealing with the Chinese health authorities including NMPA (formerly CFDA) and CDE.
- A successful track record of supporting top 50 pharma companies as well as biotech and medtech with market entry into China.
See you there!
– Accestra Events Team
